Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 10.21B | 6.86B | 12.74B | 4.96B | 2.78B | 2.72B |
Gross Profit | 6.97B | 3.48B | 7.28B | 3.92B | 2.14B | 2.04B |
EBITDA | 6.41B | 3.50B | 7.95B | 4.27B | 1.99B | 1.55B |
Net Income | 2.57B | 65.78M | 4.16B | 1.82B | 906.87M | 1.06B |
Balance Sheet | ||||||
Total Assets | 78.33B | 77.65B | 72.60B | 56.12B | 48.51B | 36.50B |
Cash, Cash Equivalents and Short-Term Investments | 2.68B | 3.96B | 2.58B | 3.02B | 1.19B | 1.81B |
Total Debt | 51.82B | 50.88B | 45.22B | 34.49B | 30.05B | 19.47B |
Total Liabilities | 59.23B | 58.61B | 53.46B | 40.50B | 34.50B | 22.62B |
Stockholders Equity | 19.10B | 19.04B | 19.15B | 15.62B | 14.01B | 13.88B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -5.54B | -3.24B | -4.99B | -13.43B | -7.70B |
Operating Cash Flow | 0.00 | 553.47M | 8.60B | 3.48B | -2.43B | 219.61M |
Investing Cash Flow | 0.00 | -4.92B | -14.56B | -5.89B | -9.19B | -5.46B |
Financing Cash Flow | 0.00 | 5.49B | 5.31B | 4.23B | 10.78B | 6.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥38.97B | 8.74 | 3.83% | 7.88% | 39.72% | ||
77 Outperform | ¥29.69B | 11.20 | 3.34% | -0.38% | 6.16% | ||
77 Outperform | ¥29.67B | 8.57 | 2.11% | 36.47% | 454.90% | ||
75 Outperform | ¥30.29B | 9.18 | 3.30% | 3.61% | -14.91% | ||
73 Outperform | ¥24.67B | 9.77 | 5.01% | 6.47% | -6.67% | ||
62 Neutral | $34.85B | 5.63 | -12.19% | 2.01% | 5.91% | -17.91% | |
61 Neutral | ¥36.08B | 524.94 | 5.61% | -46.16% | -98.25% |